ImageneBio Statistics

Total Valuation

ImageneBio has a market cap or net worth of $160.01 million. The enterprise value is $163.06 million.

Market Cap	160.01M
Enterprise Value	163.06M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ImageneBio has 11.18 million shares outstanding.

Current Share Class	11.18M
Shares Outstanding	11.18M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+43.76%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	11.24%
Float	10.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.19
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	37.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-174.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	280.54%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ImageneBio has paid $13,000 in taxes.

Income Tax	13,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.96%
50-Day Moving Average	16.11
200-Day Moving Average	16.93
Relative Strength Index (RSI)	40.17
Average Volume (20 Days)	32,695

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ImageneBio had revenue of $4.30 million and -$32.35 million in losses. Loss per share was -$0.08.

Revenue	4.30M
Gross Profit	4.30M
Operating Income	-20.56M
Pretax Income	n/a
Net Income	-32.35M
EBITDA	-20.02M
EBIT	-20.56M
Loss Per Share	-$0.08

Full Income Statement

Balance Sheet

The company has $4.92 million in cash and $8.08 million in debt, giving a net cash position of -$3.16 million or -$0.28 per share.

Cash & Cash Equivalents	4.92M
Total Debt	8.08M
Net Cash	-3.16M
Net Cash Per Share	-$0.28
Equity (Book Value)	-7.51M
Book Value Per Share	-0.41
Working Capital	-13.03M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-19.38M
Capital Expenditures	n/a
Free Cash Flow	-19.38M
FCF Per Share	-$1.73

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-478.09%
Pretax Margin	-472.51%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ImageneBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-20.23%
FCF Yield	-12.12%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ImageneBio has an Altman Z-Score of -26.69 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-26.69
Piotroski F-Score	1